
Adrenomed
Developer of clinical-stage pharmaceutical products designed to improve vascular integrity. The company's products use biomarker-guided monoclonal antibody therapies, which offer causative and safe tr...
Valuation
$0
Share Price
N/A
Total Raised
$61.3M
Last Round
N/A